Annual Accounts Receivable
$60.70 K
-$20.90 K-25.61%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual accounts receivable is $60.70 thousand, with the most recent change of -$20.90 thousand (-25.61%) on December 1, 2023.
- During the last 3 years, XRTX annual accounts receivable has risen by +$49.40 thousand (+437.17%).
- XRTX annual accounts receivable is now -25.61% below its all-time high of $81.60 thousand, reached on December 31, 2022.
Performance
XRTX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$13.10 K
-$9700.00-42.54%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly accounts receivable is $13.10 thousand, with the most recent change of -$9700.00 (-42.54%) on September 1, 2024.
- Over the past year, XRTX quarterly accounts receivable has dropped by -$47.60 thousand (-78.42%).
- XRTX quarterly accounts receivable is now -93.23% below its all-time high of $193.50 thousand, reached on June 30, 2022.
Performance
XRTX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
XRTX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.6% | -78.4% |
| 3 y3 years | +437.2% | -64.0% |
| 5 y5 years | +173.4% | -64.0% |
XRTX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.6% | +50.3% | -93.2% | at low |
| 5 y | 5-year | -25.6% | +437.2% | -93.2% | +15.9% |
| alltime | all time | -25.6% | -100.0% | -93.2% | -100.0% |
XORTX Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.10 K(-42.5%) |
| Jun 2024 | - | $22.80 K(-26.2%) |
| Mar 2024 | - | $30.90 K(-49.1%) |
| Dec 2023 | $60.70 K(-25.6%) | $60.70 K(-11.0%) |
| Sep 2023 | - | $68.20 K(+124.3%) |
| Jun 2023 | - | $30.40 K(-16.5%) |
| Mar 2023 | - | $36.40 K(-55.5%) |
| Dec 2022 | $81.60 K(+102.0%) | $81.80 K(+29.2%) |
| Sep 2022 | - | $63.30 K(-67.3%) |
| Jun 2022 | - | $193.50 K(+55.0%) |
| Mar 2022 | - | $124.80 K(+206.6%) |
| Dec 2021 | $40.40 K(+257.5%) | - |
| Dec 2021 | - | $40.70 K(+260.2%) |
| Dec 2020 | $11.30 K | $11.30 K(-28.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $15.80 K(-56.1%) |
| Jun 2019 | - | $36.00 K(+62.9%) |
| Mar 2019 | - | $22.10 K(-0.5%) |
| Dec 2018 | $22.20 K(+1607.7%) | $22.20 K(+2.3%) |
| Sep 2018 | - | $21.70 K(+1569.2%) |
| Dec 2017 | $1300.00(>+9900.0%) | $1300.00(+18.2%) |
| Nov 2017 | - | $1100.00(-38.9%) |
| Aug 2017 | - | $1800.00(>+9900.0%) |
| Feb 2017 | $0.00(-100.0%) | $0.00(-100.0%) |
| Aug 2016 | - | $200.00(-85.7%) |
| Feb 2016 | $1400.00(-82.7%) | $1400.00(-30.0%) |
| Nov 2015 | - | $2000.00(-37.5%) |
| Aug 2015 | - | $3200.00(+68.4%) |
| May 2015 | - | $1900.00(-76.5%) |
| Feb 2015 | $8100.00 | $8100.00 |
FAQ
- What is XORTX Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for XORTX Therapeutics?
- What is XORTX Therapeutics annual accounts receivable year-on-year change?
- What is XORTX Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly accounts receivable year-on-year change?
What is XORTX Therapeutics annual accounts receivable?
The current annual accounts receivable of XRTX is $60.70 K
What is the all time high annual accounts receivable for XORTX Therapeutics?
XORTX Therapeutics all-time high annual accounts receivable is $81.60 K
What is XORTX Therapeutics annual accounts receivable year-on-year change?
Over the past year, XRTX annual accounts receivable has changed by -$20.90 K (-25.61%)
What is XORTX Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of XRTX is $13.10 K
What is the all time high quarterly accounts receivable for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly accounts receivable is $193.50 K
What is XORTX Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, XRTX quarterly accounts receivable has changed by -$47.60 K (-78.42%)